10-K 1 domk_10k.htm FORM 10-K domk_10k.htm

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended May 31, 2015

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 333-136247

 

DOMARK INTERNATIONAL, INC.

(Name of small business issuer as specified in its charter)

 

Nevada

20-4647578

(State of Incorporation)

(IRS Employer Identification No.)

 

34 King Street E. Suite 1102

Toronto, Ontario, Canada M5C1E9

(Address of principal executive offices)

 

321-250-4996

(Registrant's telephone number, including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.001 Par Value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No x

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

o

Accelerated filer

¨

Non-accelerated filer

¨

Smaller Reporting Company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act. Yes o No x

 

The aggregate market value of voting stock held by non-affiliates of the registrant on May 31, 2015 was $3,750,000.

 

As of May 31, 2015 there were 8,805,932,169 shares of Common Stock, $0.001 par value per share, issued and outstanding and there were 50,000 shares of Preferred Stock, $0.001 par value per share, issued and outstanding.

 

 

 

TABLE OF CONTENTS

 

PART I

 

 

ITEM 1.

BUSINESS

3

 

ITEM 1A.

RISK FACTORS

4

 

ITEM 1B.

UNRESOLVED STAFF COMMENTS

4

 

ITEM 2.

PROPERTIES

4

 

ITEM 3.

LEGAL PROCEEDINGS

4

 

ITEM 4.

MINE SAFETY DISCLOSURES

5

 

 

PART II

 

 

ITEM 5.

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

6

 

ITEM 6.

SELECTED FINANCIAL DATA

7

 

ITEM 7.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

7

 

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

9

 

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

10

 

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

47

 

ITEM 9A.

CONTROLS AND PROCEDURES

47

 

ITEM 9B.

OTHER INFORMATION

47

 

 

PART III

 

 

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, CONTROL PERSONS AND CORPORATE GOVERNANCE COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

48

 

ITEM 11.

EXECUTIVE COMPENSATION

49

 

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

50

 

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

51

 

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

52

 

 

PART IV

 

 

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

53

 

 

SIGNATURES

56

 

 

 
Page 2 of 56
 

 

PART I

 

ITEM 1. BUSINESS

 

Except for historical information contained herein, the following discussion contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding future events and the Company's plans and expectations. Actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences include, but are not limited to, those discussed elsewhere in this Form 10-K or incorporated herein by reference, including those set forth in MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

 

HISTORY AND GENERAL OVERVIEW

 

DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. In 2008, the Company embarked on a business plan that was intended to acquire profitable businesses that would create shareholder value in diverse industries. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement for the exchange of common stock (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as Victory Lane (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement. Litigation between the Company and various parties pertaining to the Victory Lane Business remains outstanding. (Refer to "Item 3, Legal Proceedings" below).

 

On February 29, 2012, the Company formed a new wholly owned subsidiary, SolarWerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics.

 

On June 20, 2012, the Company formed a new wholly owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system, Barefoot Science. This entity is currently in default with the Nevada Secretary of State.

 

On July 20, 2012, the Company formed a new wholly owned subsidiary, Domark Canada Inc. in the province of Ontario for the purpose of supporting the Company's corporate operations based in Toronto, Ontario, Canada.

 

In December 2012, we entered into a global sales and distribution agreement with BioHarmonics Technology to develop and sell the new patent pending IR charger for all Apple iPhoneÒ models and Samsung SIII and S4 models. The IR charger has a high density backup battery which is designed to double the battery life of a smartphone. The IR charger cell can be used to recharge the phone in emergency by sun or normal room lights. This product will have a range of different lines from a low cost model up to designer products. We are aiming to launch the product later this year.

 

On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. ("Zaktek"). Zaktek's main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones including the Apple iPhoneÒ and Samsung Galaxy to improve functionality including video and gaming abilities.

 

On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.

 

In June 2013, the Company entered into an agreement to purchase 29% of Imagic for stock and cash. Imagic is a UK company that has patented, or patent pending, smartphone products. Domark is actively involved with the management and marketing direction of Imagic. Domark increased its holding in Imagic to 34% in September 2013.

 

EMPLOYEES

 

As of fiscal years ending May 31, 2015, and May 31, 2014 the Company conducts its business through independent contractors.

   

 
Page 3 of 56
 

 

ITEM 1A. RISK FACTORS

 

Not applicable to smaller reporting companies.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

Not applicable to smaller reporting companies.

 

ITEM 2. PROPERTIES

 

In August 2013, we relocated our corporate office to Toronto, Canada. As a result, the Company rented 1347 square feet of office space in Toronto. This lease is for a five year period. This office has 1347 square feet of office space. Our rent expense is approximately $1,600 per month, which increases to approximately $1,900 for the following year, and approximately $2,100 for succeeding years. We believe that this space is adequate for our current needs.

 

ITEM 3. LEGAL PROCEEDINGS

 

On May 21, 2009, the Company entered into an Agreement for the Exchange of Common Stock (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as Victory Lane (the "Victory Lane Business") pursuant to which the Company intended to purchase the Victory Lane Business. Shortly thereafter, a dispute arose between the Company and Victory Lane regarding alleged misrepresentations made by Victory Lane in connection with the Victory Lane Agreement.

 

In August, 2009, Victory Lane Financial Elite, LLC, Legacy Development, LLC and Patrick Costello filed suit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009-V-381-JW) against the Company, R. Thomas Kidd and various officers and directors of the Company, alleging that the Company was in breach of the Victory Lane Agreement and that the Company and certain of the individual defendants had committed various torts against the plaintiffs and that certain of the individual defendants had violated various fiduciary and other duties owed to the plaintiffs in connection with the Victory Lane Agreement and the handling of the Victory Lane Business (the "VLFE Case"). The plaintiffs sought a declaratory judgment to the effect that the Victory Lane Agreement had not been executed, as well as money damages from the Company and the individual defendants. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and have asserted various counterclaims including fraud and other torts. In July 2010 the court dismissed all of the individual defendants, other than R. Thomas Kidd, in response to a motion to dismiss for lack of jurisdiction. The case has since been stayed.

 

 

Page 4 of 56

 

  

In December, 2009, AHIFO-21, LLC filed a lawsuit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009-V-672-JS) against Victory Lane, LLC, Patrick J. Costello and Stephen Brown (the "Victory Lane Defendants") alleging that the Victory Lane Defendants owe the plaintiff more than $7,740,000 in respect of one or more loans made by the plaintiff to certain Victory Lane Defendants in connection with the Victory Lane Business (the "AHIFO Case"). In February 2010, the Victory Lane Defendants filed a Third Party Complaint against the Company and R. Thomas Kidd, claiming that the Company and Mr. Kidd should be liable for any amounts the Victory Lane Defendants are required to pay to the plaintiff in this case. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and Mr. Kidd has asserted various counterclaims including fraud and other torts. The Company and Mr. Kidd filed a motion to dismiss the Third Party Complaint, but the entire case was subsequently stayed.

 

Because each of the VLFE Case and the AHIFO Case have been stayed and because discovery in those cases is not complete, the Company has determined that the probability of any loss is remote and that the amount of any damages, if any were determined adverse to the Company, would not be reasonably estimable. The Company believes that it has meritorious claims against the opposing parties with respect to the Victory Lane Agreement and that the claims asserted against it are not meritorious. The Company intends to defend itself vigorously.  

 

On January 24, 2012, the Company was made aware by its former Chief Executive Officer that a complaint had been filed against the Company for approximately $534,000 by the United States Trustee for the Middle District of Florida to claim against funds we owed to our former Chief Executive Officer and his wife. On January 23, 2012, the Trustee's Motion for Approval and Notice of Compromise was filed to obtain the approval of the court of a settlement of the matters that were the subject of the complaint. On April 24, 2012, the Company was advised that the complaint, which was never served, was dismissed with prejudice by the US Trustee.

 

Currently, as of May 31, 2015 the Company's attorneys are actively defending the claim, and have ten of the twelve counts dismissed on the suit. Management feels that this issue is without merit and will prevail.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.  

 

 
Page 5 of 56
 

 

PART II

 

ITEM 5. MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our common stock is traded in the over-the-counter market and is quoted on the OTCQB quotation service operated by OTC Markets Group, Inc.

 

There were 8,805,932,169 and 801,626,781 shares of our common stock issued and outstanding, as of May 31, 2015 and May 31, 2014 respectively. There were approximately 5,000 shareholders of record of the Company's common stock.

 

The following table sets forth for the periods indicated the high and low bid quotations for our common stock. These quotations represent inter-dealer quotations, without adjustment for retail markup, markdown or commission and may not represent actual transactions.

 

FISCAL YEAR ENDED MAY 31, 2013

 

 

 

F/Y 2015

 

 

F/Y 2014

 

 

 

High

 

 

Low

 

 

High

 

 

Low

 

 

 

 

 

 

 

 

 

 

 

 

 

 

First Quarter (June - August)

 

$ 0.0003

 

 

$ 0.002

 

 

$ 0.14

 

 

$ 0.05

 

Second Quarter (September - November)

 

$ 0.0004

 

 

$ 0.0001

 

 

$ 0.07

 

 

$ 0.01

 

Third Quarter (December - February)

 

$ 0.0001

 

 

$ 0.0001

 

 

$ 0.02

 

 

$ 0.01

 

Fourth Quarter (March - May)

 

$ 0.0001

 

 

$ 0.0001

 

 

$ 0.001

 

 

$ 0.001

 

 

DIVIDENDS

 

The Company has never paid dividends on any shares of its common stock, nor does the Company anticipate paying dividends at any time in the foreseeable future. Any profits received by the Company will be reinvested in its business.

 

RECENT SALES OF UNREGISTERED SECURITIES

 

On June 17, 2013, the Company issued 2,500,000 shares of common stock for a related party loan conversion.

 

On June 18, 2013, the Company issued 3,160,000 shares of common stock for consulting services.

 

On June 29, 2013, the Company issued 2,500,000 shares of common stock for consulting services.

 

On July 5, 2013, the Company issued 250,000 shares of common stock for consulting services.

 

On July 17, 2013, the Company issued 575,000 shares of common stock for consulting services.

   

 
Page 6 of 56
 

 

On July 22, 2013, the Company issued 7,500,000 shares of common stock purchased 100% of South Hill Ltd., an English private limited company, which owned 19% of Zaktek.

 

On July 24, 2013, the Company issued 2,874,550 shares of common stock for a related party loan conversion.

 

On August 14, 2013, the Company issued 500,000 shares of common stock for patent purchased on April 16, 2013 and settled the stock payable 500,000 shares recorded as of May 31, 2013. The aggregate value of the stock at time of issuance was $40,000.

 

On August 26, 2013, the Company issued 2,000,000 shares of common stock for consulting services.

 

On August 28, 2013, the Company issued 1,114,206 shares of common stock for conversion of Asher convertible note.

 

The Company claims an exemption from registration for the above issuances pursuant to Section 4(a)(2) of the Securities Act due to the small number of purchasers and their sophistication in financial and business matters. The Company claims an exemption under Section 3(a)(9) of the Securities Act for issuances of common stock pursuant to each note conversion described above.

 

ITEM 6. SELECTED FINANCIAL DATA

 

Not applicable to smaller reporting companies.

 

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following is management's discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying consolidated financial statements, as well as information relating to the current plans of our management. This report includes forward-looking statements. Generally, the words "believes", "anticipates", "may", "will", "should", "expect", "intend", "estimate", "continue", and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

 

The following discussion and analysis should be read in conjunction with our consolidated financial statements and the related notes thereto and other financial information contained elsewhere in this Form 10-K.

 

RECENT DEVELOPMENTS

 

The main operations of the Company have been to search, negotiate and acquire ownership interests in companies with products at an advanced stage of their development or products already in production. The Company has a revised direction, along with development stage products, for online shopping networks. This is evidenced by the licensing agreement with Wazzamba. S.A. for the North American licensing rights for our private label online shopping network, referred to as "Simbadeals".  

 

 
Page 7 of 56
 

 

In December 2013, the Company increased its equity interest in Imagic Ltd. to 40%. Imagic is a company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products.

 

In January 2014, the Company acquired United States and Canada marketing rights to certain online shop technology pursuant to a Licensing Agreement with Wazzamba SA.

 

On February 24, 2014, the Company increased the number of authorized shares of common stock to 900,000,000 shares.

 

On June 15, 2014, the Company increased the number of authorized shares of common stock to 2,000,000,000 shares.

 

On June 19, 2014, the Company increased the number of authorized shares of common stock to 3,000,000,000 shares.

 

On August 11, 2014 the Company increased the number of authorized shares of common stock to 4,000,000,000 shares.

 

On December 1, 2014, R. Brentwood Strasler, Non-Exec Chairman, resigned from Company, mutually agreed upon by President and CEO.

 

On December 9, 2014, the Company increase the number of authorized shares of common stock to 14,000,000,000 shares.

 

FISCAL YEAR ENDED MAY 31, 2015 COMPARED TO FISCAL YEAR ENDED MAY 31, 2014

 

The Company did not have any revenues for fiscal year ending May 31, 2015 and for the fiscal year ended May 31, 2014.

 

General and administrative expenses for fiscal 2015 decreased to $1,102,920 as compared to $1,027,248 in fiscal 2014. The increase is primarily related to an increase of consultants, and decreased professional fees. In fiscal year 2014 the Company placed on hold the sale of Solawerks products. Interest expense for the twelve months ending May 31, 2015 was $805,370 as compared to $511,876 for the period ending May 31, 2014. The Company's operations during fiscal 2015 were funded by convertible promissory notes, through a plethora of lenders.

 

The operating loss for fiscal 2015 decreased to $3,020,655 as compared to $3,638,318 for fiscal 2014. The primary decrease in the operating loss was due to a major reduction of operating expenses, stock based compensation, and the revaluation of the derivative liability account.

 

No tax benefit was recorded for fiscal 2015 or fiscal 2014 as required by ASC Standard 740-25, Accounting for Income Taxes. The Company has provided for a 100% allowance of its deferred tax assets, as it is uncertain that there will be sufficient net profits in the future to fully realize the tax benefit of its net operating loss carry-forwards.  

 

 
Page 8 of 56
 

 

LIQUIDITY AND CAPITAL RESOURCES

 

Our operating requirements have been funded primarily through financing facilities and sales of our common stock. The Company will continue to require financing from loans and notes payable until such time our business has generated income sufficient to carry our operating costs.

 

Cash used in operating activities for the fiscal year 2015 was $303,239 compared to $1,323,233 for the fiscal year 2014. Depreciation and amortization expense for fiscal year 2015 was $217,440 as compared to $62,685 for fiscal 2014. The decrease was due primarily to a reduction of consultant pay, and the derivative liability evaluation adjustment for the Company.

 

Cash used in investing activities was $0 for the fiscal year 2015, compared to $195,753 for the fiscal year 2014.

 

Cash provided by financing activities was $340,566 for fiscal year 2015 as compared to $1,519,426 for fiscal 2014. Financing activities consisted of cash received from shareholders and notes payable.

 

OTHER CONSIDERATIONS

 

There are numerous factors that affect the Company's business and the results of its operations. Sources of these factors include general economic and business conditions, federal and state regulation of business activities, the level of demand for services, the level and intensity of competition in the, and our ability to continue to improve our infrastructure, including personnel and systems, to keep pace with our anticipated rapid growth in the development of our business.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.  

 

 
Page 9 of 56
 

 

ITEM 8. FINANCIAL STATEMENTS

 

DOMARK INTERNATIONAL, INC.

 

TABLE OF CONTENTS

 

Page

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

11

CONSOLIDATED FINANCIAL STATEMENTS:

Consolidated Balance Sheets at May 31, 2015 and 2014

12-13

Consolidated Statements of Operations for the years ended May 31, 2015 and 2014

14

Consolidated Statements of Stockholders' Deficit for the years ended May 31, 2015 and 2014

15-26

Consolidated Statements of Cash Flows for the years ended May 31, 2015 and 2014

27-28

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

29-46

 

 
Page 10 of 56
 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Domark, International Inc.

Longwood, Florida

 

We have audited the accompanying consolidated balance sheets of Domark International Inc. as of May 31, 2015 and 2014, and the related statements of operations, stockholders’ deficit and cash flows for each of the years in the two year period ended May 31, 2015. Domark International Inc.’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Domark International Inc. as of May 31, 2014, and 2013, and the results of its operations and its cash flows for each of the years in the two year period ended May 31, 2014, in conformity with accounting principles generally accepted in the United States of America.

 

 

/s/ ZBS Group, LLP


Plainview, NY

September 14, 2015

 
Page 11 of 56
 

 

DOMARK INTERNATIONAL, INC. 

CONSOLIDATED BALANCE SHEETS

 

 

 

May 31,

 

 

May 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$ -

 

 

$ 460

 

Loan receivable from consultant

 

 

36,203

 

 

 

36,203

 

Prepaid expenses

 

 

4,500

 

 

 

4,500

 

TOTAL CURRENT ASSETS

 

 

40,703

 

 

 

41,163

 

 

 

 

 

 

 

 

 

 

INVESTMENTS

 

 

1,144,166

 

 

 

1,144,166

 

 

 

 

 

 

 

 

 

 

OTHER ASSETS

 

 

 

 

 

 

 

 

Patents, net of accumulated amortization of $13,605 and $3,605, respectively

 

 

56,897

 

 

 

66,897

 

Licenses, net of accumulated amortization of $268,338 and $60,898 respectively

 

 

41,662

 

 

 

249,102

 

TOTAL OTHER ASSETS

 

 

98,559

 

 

 

315,999

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$ 1,283,428

 

 

$ 1,501,328

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 12 of 56
 

 
DOMARK INTERNATIONAL, INC.
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' (DEFICIT)

 

 

 

May 31,

 

 

May 31,

 

 

 

2015

 

 

2014

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Amounts payable to Bank

 

$ 115

 

 

 

-

 

Note payable to bank

 

 

198,000

 

 

$ 180,000

 

Accounts payable and accrued expenses

 

 

855,665

 

 

 

56,940

 

Amounts due under Licensing Agreement with Wazzamba SA

 

 

224,924

 

 

 

224,925

 

Loans payable to consultants and stockholders

 

 

189,928

 

 

 

188,972

 

Convertible notes payable (net of unamortized discounts of $58,938 and $674,886 respectively)

 

 

580,956

 

 

 

67,414

 

Derivative liability for convertible notes payable

 

 

2,564,280

 

 

 

1,748,982

 

TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES

 

 

4,613,868

 

 

 

2,467,233

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, authorized 10,000,000 shares:

 

 

 

 

 

 

 

 

Series A convertible preferred stock - issued and outstanding 50,000 shares as of May 31, 2015 and May 31, 2014

 

 

50

 

 

 

50

 

Convertible preferred stock series B, $0.0001 par value,

 

 

 

 

 

 

 

 

Authorized: 10,000,000

 

 

-

 

 

 

-

 

Common stock, $0.001 par value, authorized 14,000,000,000 shares:

 

 

 

 

 

 

 

 

8,805,932,169 and 801,626,781 shares issued, and 8,681,112,367 and 676,806,979 shares outstanding as of May 31, 2015 and May 31, 2014

 

 

8,805,932

 

 

 

801,627

 

Less: Treasury stock (124,819,802 shares) as of May 31, 2015 and May 31, 2014

 

 

(124,820 )

 

 

(124,820 )

Common stock payable

 

 

858,000

 

 

 

858,000

 

Additional paid in capital

 

 

36,219,642

 

 

 

43,529,923

 

Other comprehensive income ( loss )

 

 

(126,453 )

 

 

(88,551 )

Accumulated deficit

 

 

(48,962,791 )

 

 

(45,942,134 )
 

 

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS' DEFICIT

 

 

(3,330,440 )

 

 

(965,905 )
 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

$ 1,283,428

 

 

$ 1,501,328

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 13 of 56
 

 

DOMARK INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

For the Years Ended

 

 

 

May 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

Sales

 

$ -

 

 

$ -

 

Cost of sales

 

 

-

 

 

 

-

 

Gross profit

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

General and administrative

 

 

1,102,920

 

 

 

1,027,248

 

Stock-based compensation - Consultants

 

 

79,623

 

 

 

666,755

 

Stock-based compensation - Salaries and wages

 

 

-

 

 

 

156,600

 

Depreciation and amortization expense

 

 

217,440

 

 

 

62,685

 

Total operating expenses

 

 

1,399,983

 

 

 

1,913,288

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,399,983 )

 

 

(1,913,288 )
 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Other income

 

 

-

 

 

 

-

 

Revaluation of derivative liability for

 

 

 

 

 

 

 

 

convertible notes

 

 

(815,302 )

 

 

(1,213,154 )

Interest expense

 

 

(805,370 )

 

 

(511,876 )

Total other income (expense)

 

 

(1,620,672 )

 

 

(1,725,030 )
 

 

 

 

 

 

 

 

 

Net Loss

 

 

(3,020,655 )

 

 

(3,638,318 )
 

 

 

 

 

 

 

 

 

Statement of Comprehensive Income:

 

 

 

 

 

 

 

 

Net Loss

 

 

(3,020,655 )

 

 

(3,638,318 )
 

 

 

 

 

 

 

 

 

Other Comprehensive loss

 

 

 

 

 

 

 

 

Foreign currency adjustment

 

 

(37,902 )

 

 

(88,551 )
 

 

 

(37,902 )

 

 

(88,551 )
 

 

 

 

 

 

 

 

 

Total Comprehensive Loss

 

$ (3,058,557 )

 

$ (3,726,869 )
 

 

 

 

 

 

 

 

 

Net loss per common shares, basic and diluted

 

$ 0.00

 

 

$ (0.01 )

Weighted average common shares outstanding

 

 

4,709,452,486

 

 

 

298,705,632

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 14 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

During Dev.

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Shares

 

 

Amt

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Stage

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance May 31, 2013

 

 

50,000

 

 

 

50

 

 

 

179,435,100

 

 

 

179,435

 

 

 

40,816,440

 

 

 

858,000

 

 

 

(42,303,816 )

 

 

(124,819,802 )

 

 

(124,820 )

 

 

-

 

 

 

(574,711 )
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for related party loan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June17,2013

 

 

 

 

 

 

 

 

 

 

2,500,000

 

 

 

2,500

 

 

 

47,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

50,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for consulting (Meadow)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6/29/2013($.101)x

 

 

 

 

 

 

 

 

 

 

2,500,000

 

 

 

2,500

 

 

 

247,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

250,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for web development(KC)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7/5/2013($.09)

 

 

 

 

 

 

 

 

 

 

250,000

 

 

 

250

 

 

 

22,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comon Stock issued for

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment Tech

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7/9/2013($.089)

 

 

 

 

 

 

 

 

 

 

75,000

 

 

 

75

 

 

 

6,600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,675

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for IR consulting(Davis)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7/17/2013($.0833)

 

 

 

 

 

 

 

 

 

 

500,000

 

 

 

500

 

 

 

41,150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

41,650

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Common Stock issed for

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related party loan(FMK)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July22,2013

 

 

 

 

 

 

 

 

 

 

2,874,550

 

 

 

2,875

 

 

 

54,616

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

57,491

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for acquisition(Imagic)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July22,2013

 

 

 

 

 

 

 

 

 

 

7,500,000

 

 

 

7,500

 

 

 

690,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

697,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for consulting Bio Harmon.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8/15/2013($.071)issue($.01)

 

 

 

 

 

 

 

 

 

 

500,000

 

 

 

500

 

 

 

35,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for consulting(Meadow)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8/26/2013($.0655)

 

 

 

 

 

 

 

 

 

 

2,000,000

 

 

 

2,000

 

 

 

131,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

133,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for loan conversion(Asher)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8/28/2013($.0359)

 

 

 

 

 

 

 

 

 

 

1,114,206

 

 

 

1,114

 

 

 

38,886

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40,000

 

 

 
Page 15 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

Shares

Amt

Shares

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher 9/18/13 ($25K)

 

 

 

 

 

 

 

 

 

 

856,164

 

 

 

856

 

 

 

24,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25,000

 

Bal. of loan ($14.5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

1,000,000

 

 

 

1,000

 

 

 

44,600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45,600

 

Caramel ( 10/9/13)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

250,000

 

 

 

250

 

 

 

12,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,500

 

(Kauffman) 10/10/13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (11/14/13) ($14.5k)

 

 

 

 

 

 

 

 

 

 

903,261

 

 

 

903

 

 

 

13,594

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,497

 

Bal. of loan ( $0)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (11/4/13) ($$15k)

 

 

 

 

 

 

 

 

 

 

1,153,846

 

 

 

1,154

 

 

 

13,847

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,001

 

Bal. of loan ($33750)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

party loan ( Frmk) (11/7/13)

 

 

 

 

 

 

 

 

 

 

3,500,000

 

 

 

3,500

 

 

 

49,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

52,500

 

$52.5k Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (11/12/13) ($15K)

 

 

 

 

 

 

 

 

 

 

1,630,435

 

 

 

1,631

 

 

 

13,370

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,001

 

Bal. of loan ($18,750)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (11/14/13) ($13,197)

 

 

 

 

 

 

 

 

 

 

3,999,200

 

 

 

3,999

 

 

 

9,198

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,197

 

Bal. of loan ($36,603)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Kauffman) 11/15/13

 

 

 

 

 

 

 

 

 

 

175,000

 

 

 

175

 

 

 

1,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (11/19/13) ($18.5K)

 

 

 

 

 

 

 

 

 

 

3,456,597

 

 

 

3,457

 

 

 

16,588

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,045

 

Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (11/19/13) ($22,126)

 

 

 

 

 

 

 

 

 

 

8,850,572

 

 

 

8,850

 

 

 

13,276

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22,126

 

Bal. of loan ($14,852)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Page 16 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for investment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

in Imagic (12/3/13) $.0125

 

 

 

 

 

 

 

 

 

 

8,000,000

 

 

 

8,000

 

 

 

91,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

99,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (12/4/13) ($14,852)

 

 

 

 

 

 

 

 

 

 

7,072,457

 

 

 

7,072

 

 

 

7,780

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,852

 

Bal. of loan ($0) $.099

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Icon/FrMk (12/18/13) ($11,435)

 

 

 

 

 

 

 

 

 

 

5,445,005

 

 

 

5,445

 

 

 

5,990

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11,435

 

Bal. of loan ($38,565)$.01

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (12/26/13) ($20K)

 

 

 

 

 

 

 

 

 

 

4,166,667

 

 

 

4,167

 

 

 

15,833

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,000

 

Bal. of loan ($30,050)$.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (12/30/13) ($23K)

 

 

 

 

 

 

 

 

 

 

4,791,667

 

 

 

4,792

 

 

 

18,208

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23,000

 

Bal. of loan ($7,050)$.0125

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (1/6/14) ($7,050)

 

 

 

 

 

 

 

 

 

 

1,305,556

 

 

 

1,306

 

 

 

5,744

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,050

 

Bal. of loan ($0)$.01

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic/FrMk (1/13/14) ($13,017)

 

 

 

 

 

 

 

 

 

 

6,198,762

 

 

 

6,199

 

 

 

6,818

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,017

 

Bal. of loan ($25,548)$.009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic/FrMk (1/23/14) ($14K)

 

 

 

 

 

 

 

 

 

 

6,436,781

 

 

 

6,437

 

 

 

7,563

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,000

 

Bal of loan ($11,548) $.009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic/FrMk (2/3/14) ($14,998)

 

 

 

 

 

 

 

 

 

 

7,498,890

 

 

 

7,499

 

 

 

7,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,998

 

Bal of loan ($0) $.009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (2/6/14) ($17,150)

 

 

 

 

 

 

 

 

 

 

4,900,000

 

 

 

4,900

 

 

 

12,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,150

 

Bal of loan ($7,850) $.0082

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (2/11/14) ($10,800)

 

 

 

 

 

 

 

 

 

 

3,000,000

 

 

 

3,000

 

 

 

7,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,800

 

Bal of loan ($11,548) $.0088

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cont. Eq. (2/11/14) ($20k)

 

 

 

 

 

 

 

 

 

 

4,901,960

 

 

 

4,902

 

 

 

15,098

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,000

 

Bal of loan ($10K)$.0088

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Page 17 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Additional

Paid in

 

 

Common

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Total

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Blk Mtn (2/13/14) ($15k)

Bal of loan ($45.5)$.0088

 

 

 

 

 

 

 

 

 

 

5,000,000

 

 

 

5,000

 

 

 

10,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

JMJ (2/25/14) ($12k)

Bal of loan ($27,200) $.0055

 

 

 

 

 

 

 

 

 

 

4,000,000

 

 

 

4,000

 

 

 

8,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Cont. Eq. (2/26/14) ($10k)

Bal of loan ($0) $.0056

 

 

 

 

 

 

 

 

 

 

3,278,688

 

 

 

3,279

 

 

 

6,721

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Thorsteinson) 3/3/14/$.0067

 

 

 

 

 

 

 

 

 

 

12,000,000

 

 

 

12,000

 

 

 

68,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

80,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/3/14) ($10,913)

 

 

 

 

 

 

 

 

 

 

6,419,120

 

 

 

6,419

 

 

 

4,494

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,913

 

Bal of loan ($84,087)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/6/14) ($10,133)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($73,955)

 

 

 

 

 

 

 

 

 

 

6,755,135

 

 

 

6,755

 

 

 

3,378

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,133

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (3/6/14) ($9,178)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($0)

 

 

 

 

 

 

 

 

 

 

3,990,435

 

 

 

3,990

 

 

 

5,188

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,178

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/6/14) ($10,663)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($63,292)

 

 

 

 

 

 

 

 

 

 

7,108,733

 

 

 

7,109

 

 

 

3,554

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,663

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Pre. Vnt. Partns) 3/17/14 $.0058

 

 

 

 

 

 

 

 

 

 

5,668,934

 

 

 

5,669

 

 

 

27,211

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,880

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for officers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3/17/14) AR ( 15m) TC ( 10m)

 

 

 

 

 

 

 

 

 

 

27,000,000

 

 

 

27,000

 

 

 

129,600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

156,600

 

Brent S. ( 2m ) $.0058

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (3/18/14) ($15,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($35,050)

 

 

 

 

 

 

 

 

 

 

6,818,182

 

 

 

6,818

 

 

 

8,182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/18/14) ($12,968)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($50,323)

 

 

 

 

 

 

 

 

 

 

10,053,100

 

 

 

10,053

 

 

 

2,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,968

 

 

 
Page 18 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

Preferred Stock

 

 

 

Common Stock

 

 

 

Paid in

 

 

 

Stock

 

 

 

Accumulated

 

 

 

Treasury Stock

 

 

 

 

 

 

 

Stockholders'

 

 

 

 

Amt.

 

 

 

Shares

 

 

 

Shares

 

 

 

Amt.

 

 

 

Capital

 

 

 

Payable

 

 

 

Deficit

 

 

 

Shares

 

 

 

Amount

 

 

 

OCI

 

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Bill Sharpe) 3/19/14 $.0049

 

 

 

 

 

 

 

 

 

 

2,000,000

 

 

 

2,000

 

 

 

7,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (3/20/14) ($19.5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($15,550)

 

 

 

 

 

 

 

 

 

 

8,863,636

 

 

 

8,864

 

 

 

10,636

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/24/14) ($13,187)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($37,136)

 

 

 

 

 

 

 

 

 

 

11,081,400

 

 

 

11,081

 

 

 

2,106

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,187

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (3/25/14) ($11.4k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($4,150)

 

 

 

 

 

 

 

 

 

 

6,000,000

 

 

 

6,000

 

 

 

5,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (3/28/14) ($4,150)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

2,766,667

 

 

 

2,767

 

 

 

1,383

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (3/28/14) ($6,642)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($30,495)

 

 

 

 

 

 

 

 

 

 

11,652,000

 

 

 

11,652

 

 

 

(5,010 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,642

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Blk Mtn (4/1/14) ($15k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($30.5)

 

 

 

 

 

 

 

 

 

 

17,647,059

 

 

 

17,647

 

 

 

(2,647 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (4/2/14) ($7,038)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($32,384)

 

 

 

 

 

 

 

 

 

 

6,900,000

 

 

 

6,900

 

 

 

138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,038

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (4/2/14) ($6,996)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($23,499)

 

 

 

 

 

 

 

 

 

 

12,273,600

 

 

 

12,273

 

 

 

(5,277 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (4/8/14) ($7,363)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($16,136)

 

 

 

 

 

 

 

 

 

 

12,916,695

 

 

 

12,917

 

 

 

(5,554 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,363

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Blk Mtn (4/10/14) ($15k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($15.5)

 

 

 

 

 

 

 

 

 

 

17,647,059

 

 

 

17,647

 

 

 

(2,647 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (4/10/14) ($32,384)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($0)

 

 

 

 

 

 

 

 

 

 

31,749,235

 

 

 

31,749

 

 

 

635

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,384

 

 

 
Page 19 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Additional

Paid in

 

 

Common

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Total

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

RdWd III (4/10/14) ($7,748)

Bal of loan ($8,388)

 

 

 

 

 

 

 

 

 

 

13,593,400

 

 

 

13,593

 

 

 

(5,845

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,748

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

JSJ (4/10/14) ($4,088)

Bal of loan ($20,812)

 

 

 

 

 

 

 

 

 

 

10,220,000

 

 

 

10,220

 

 

 

(6,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,088

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RdWd III (4/16/14) ($8,367)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($3,054)

 

 

 

 

 

 

 

 

 

 

14,678,154

 

 

 

14,678

 

 

 

(6,311 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,367

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Blk Mtn (4/16/14) ($15.5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($0)

 

 

 

 

 

 

 

 

 

 

15,500,000

 

 

 

15,500

 

 

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for interest on

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ loan dated 8/7/13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4/23/14)

 

 

 

 

 

 

 

 

 

 

10,900,000

 

 

 

10,900

 

 

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (4/29/14) ($14,009)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($20,812)

 

 

 

 

 

 

 

 

 

 

22,716,552

 

 

 

22,717

 

 

 

(8,708 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for BF Science

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment 5/5/14 $.003

 

 

 

 

 

 

 

 

 

 

15,000,000

 

 

 

15,000

 

 

 

30,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (5/6/14) ($15K)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($15k)

 

 

 

 

 

 

 

 

 

 

30,000,000

 

 

 

30,000

 

 

 

(15,000 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

RdWd III (5/6/14) ($8,367)

Bal of loan ($0)

 

 

 

 

 

 

 

 

 

 

4,492,470

 

 

 

4,492

 

 

 

(1,418

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,074

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Iconic (5/14/14) ($16,533K)

Bal of loan ($0k)

 

 

 

 

 

 

 

 

 

 

33,065,760

 

 

 

33,065

 

 

 

(16,532

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,533

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

JSJ (5/14/14) ($8,516)

Bal of loan (0)

 

 

 

 

 

 

 

 

 

 

15,483,636

 

 

 

15,483

 

 

 

(6,967

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,516

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

to Meadow Grove

(May 27 ,2014)$.0023

 

 

 

 

 

 

 

 

 

 

15,000,000

 

 

 

15,000

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Asher (5/28/14) ($11.4k)

Bal. of loan ($4,150)

 

 

 

 

 

 

 

 

 

 

17,545,455

 

 

 

17,545

 

 

 

1,755

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Iconic (5/29/14) ($15K)

Bal of loan ($0k)

 

 

 

 

 

 

 

 

 

 

37,500,000

 

 

 

37,500

 

 

 

(22,500

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

Iconic (5/29/14) ($15K)

Bal of loan ($0k)

 

 

 

 

 

 

 

 

 

 

17,600,000

 

 

 

17,602

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,601

 

 

 
Page 20 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock cancel for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (5/14/14) ($8,516)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan (8,516)

 

 

 

 

 

 

 

 

 

 

(15,483,636 )

 

 

(15,483 )

 

 

6,967

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,516 )
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (6/3/14) ($8,734)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal loan (0) Replace 5/14/14

 

 

 

 

 

 

 

 

 

 

19,408,888

 

 

 

19,409

 

 

 

(10,675 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,734

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (6/4/14) ($7,300)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

8,111,111

 

 

 

8,111

 

 

 

(811 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (6/11/14) ($7.5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($27.5)

 

 

 

 

 

 

 

 

 

 

14,423,077

 

 

 

14,423

 

 

 

(6,923 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (6/20/14) ($5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($22.5)

 

 

 

 

 

 

 

 

 

 

11,363,636

 

 

 

11,364

 

 

 

(6,364 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (6/24/14) ($14.4k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($47,924)

 

 

 

 

 

 

 

 

 

 

20,000,000

 

 

 

20,000

 

 

 

(5,600 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for consulting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

to Meadow Grove

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6/25/14)$.0023 ($.0011)

 

 

 

 

 

 

 

 

 

 

13,200,479

 

 

 

13,200

 

 

 

1,321

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,521

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (6/26/14) ($5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($17.5)

 

 

 

 

 

 

 

 

 

 

12,500,000

 

 

 

12,500

 

 

 

(7,500 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (6/30/14) ($16,730)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($0k)

 

 

 

 

 

 

 

 

 

 

66,920,560

 

 

 

66,921

 

 

 

(50,191 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (6/30/14) ($5.1k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($12.4k)

 

 

 

 

 

 

 

 

 

 

12,750,000

 

 

 

12,750

 

 

 

(7,650 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap. (7/2/14) ($11,509)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($39k)

 

 

 

 

 

 

 

 

 

 

28,771,780

 

 

 

28,772

 

 

 

(17,263 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11,509

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (7/10/14) ($8k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($4.4k)

 

 

 

 

 

 

 

 

 

 

28,571,429

 

 

 

28,571

 

 

 

(20,571 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (7/14/14) ($15k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($22.5k)

 

 

 

 

 

 

 

 

 

 

34,090,909

 

 

 

34,091

 

 

 

(19,091 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap.. (7/14/14) ($8,906)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($30.5k)

 

 

 

 

 

 

 

 

 

 

31,807,632

 

 

 

31,807

 

 

 

(22,901 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,906

 

 

 
Page 21 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (7/14/14) ($15k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($7.5k)

 

 

 

 

 

 

 

 

 

 

42,857,143

 

 

 

42,857

 

 

 

(27,857 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gel Prop. (7/18/14) ($4.4k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan (0)

 

 

 

 

 

 

 

 

 

 

26,660,667

 

 

 

26,661

 

 

 

(22,261 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (7/17/14) ($9k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan (0)

 

 

 

 

 

 

 

 

 

 

31,034,483

 

 

 

31,034

 

 

 

(22,034 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap.. (7/25/14) ($5,253)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($25.5k)

 

 

 

 

 

 

 

 

 

 

32,832,191

 

 

 

32,832

 

 

 

(27,579 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,253

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap.. (7/31/14) ($8k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($17.5k)

 

 

 

 

 

 

 

 

 

 

52,630,136

 

 

 

52,630

 

 

 

(44,209 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,421

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (7/31/14) ($9,840)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($38,084)

 

 

 

 

 

 

 

 

 

 

41,000,000

 

 

 

41,000

 

 

 

(31,160 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap.. (8/4/14) ($9,497)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($8.6k)

 

 

 

 

 

 

 

 

 

 

59,358,732

 

 

 

59,359

 

 

 

(49,862 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,497

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG Cap.. (8/6/14) ($9,065)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

56,659,863

 

 

 

56,660

 

 

 

(47,594 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,066

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (8/7/14) ($13,680)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($24,404)

 

 

 

 

 

 

 

 

 

 

57,000,000

 

 

 

57,000

 

 

 

(43,320 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,680

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued to Shel. Davis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

for loan repayment(8/13/14)

 

 

 

 

 

 

 

 

 

 

140,000,000

 

 

 

140,000

 

 

 

(98,898 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

41,102

 

(41,102)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (8/14/14) ($15k)

 

 

 

 

 

 

 

 

 

 

57,692,308

 

 

 

57,692

 

 

 

(42,692 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

Bal. of loan (12.5k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (8/18/14) ($14,040)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($10,364)

 

 

 

 

 

 

 

 

 

 

78,000,000

 

 

 

78,000

 

 

 

(63,960 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,040

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (8/29/14)Bal $24,575

 

 

 

 

 

 

 

 

 

 

62,753,278

 

 

 

62,753

 

 

 

(58,047 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,706

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asher (8/16/14) ($15,374)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan (0)

 

 

 

 

 

 

 

 

 

 

59,130,435

 

 

 

59,130

 

 

 

(43,756 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,374

 

 

 
Page 22 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (9/4/14) ($14,04)

 

 

 

 

 

 

 

 

 

 

70,000,000

 

 

 

70,000

 

 

 

(57,400 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,600

 

Bal. of loan ($0)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (9/4/14) ($8,538)

 

 

 

 

 

 

 

 

 

 

170,760,000

 

 

 

170,760

 

 

 

(162,222 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,538

 

Bal. of loan ($21,462)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (9/12/14)Bal $24,575

 

 

 

 

 

 

 

 

 

 

78,759,945

 

 

 

78,760

 

 

 

(74,822 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,938

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (9/19/14) ($8,538)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($23,276)

 

 

 

 

 

 

 

 

 

 

170,760,000

 

 

 

170,760

 

 

 

(162,222 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,538

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (9/19/14) ($4,692)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($27,231)

 

 

 

 

 

 

 

 

 

 

93,841,481

 

 

 

93,841

 

 

 

(89,149 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,692

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (9/19/14) ($5,014)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $16,900)

 

 

 

 

 

 

 

 

 

 

100,271,400

 

 

 

100,271

 

 

 

(95,257 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (9/19/14) ($12K)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $50,222)

 

 

 

 

 

 

 

 

 

 

100,000,000

 

 

 

100,000

 

 

 

(88,000 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (9/23/14) ($4,922)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($27,231)

 

 

 

 

 

 

 

 

 

 

98,439,714

 

 

 

98,440

 

 

 

(93,518 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,922

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (10/1/14) ($2,582)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($19,828)

 

 

 

 

 

 

 

 

 

 

103,263,260

 

 

 

103,263

 

 

 

(100,681 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (10/114) ($6,633)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($21,462)

 

 

 

 

 

 

 

 

 

 

265,320,000

 

 

 

265,320

 

 

 

(258,687 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,633

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (10/1//14) ($6.3K)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $41,686)

 

 

 

 

 

 

 

 

 

 

105,000,000

 

 

 

105,000

 

 

 

(98,700 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redwd III (10/1//14) ($2,680)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $47,320)

 

 

 

 

 

 

 

 

 

 

133,984,700

 

 

 

133,985

 

 

 

(131,305 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,680

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redwd III (10/1//14) ($2,680)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $47,320)

 

 

 

 

 

 

 

 

 

 

141,004,800

 

 

 

141,005

 

 

 

(138,185 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,820

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (10/16//14) ($3,225)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $39,275)

 

 

 

 

 

 

 

 

 

 

64,500,000

 

 

 

64,500

 

 

 

(61,275 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,225

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (10/16//14) ($4,390)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $34,885)

 

 

 

 

 

 

 

 

 

 

87,800,000

 

 

 

87,800

 

 

 

(83,410 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,390

 

 

 
Page 23 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WHC (10/16//14) ($4,624)

 

 

 

 

 

 

 

 

 

 

92,480,000

 

 

 

92,480

 

 

 

(87,856 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,624

 

Bal of loan ( $48,376)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tonaquint (10/16//14) ($4,393)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $48,376)

 

 

 

 

 

 

 

 

 

 

175,750,000

 

 

 

175,750

 

 

 

(171,356 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,394

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (10/120//14) ($7,615)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $27,220)

 

 

 

 

 

 

 

 

 

 

152,300,000

 

 

 

152,300

 

 

 

(144,685 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redwd III (10/20//14) ($2,968)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $41,532)

 

 

 

 

 

 

 

 

 

 

148,392,800

 

 

 

148,393

 

 

 

(145,425 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,968

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (10/30/14) ($3,687)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $13,400)

 

 

 

 

 

 

 

 

 

 

184,359,000

 

 

 

184,359

 

 

 

(180,672 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,687

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (11/10/14) ($7,615)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $19,655)

 

 

 

 

 

 

 

 

 

 

152,300,000

 

 

 

152,300

 

 

 

(144,685 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (11/10//14) ($8,105)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $8,538)

 

 

 

 

 

 

 

 

 

 

324,186,800

 

 

 

324,187

 

 

 

(316,082 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WHC (11/19/14) ($5,376)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $43,000)

 

 

 

 

 

 

 

 

 

 

107,520,000

 

 

 

107,520

 

 

 

(102,144 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,376

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (11/19/14) ($7615)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $12,040)

 

 

 

 

 

 

 

 

 

 

152,300,000

 

 

 

152,300

 

 

 

(144,685 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redwd III (11/19/14) ($3,123)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $38,409)

 

 

 

 

 

 

 

 

 

 

156,167,800

 

 

 

156,168

 

 

 

(153,045 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,123

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (11/1914) ($4,443)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $9,200)

 

 

 

 

 

 

 

 

 

 

222,151,000

 

 

 

222,151

 

 

 

(217,708 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,443

 

 

 
Page 24 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (11/20//14) ($5,207)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $49,793)

 

 

 

 

 

 

 

 

 

 

212,530,612

 

 

 

212,531

 

 

 

(207,324 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,207

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (12/1/14) ($4,667)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $4,800)

 

 

 

 

 

 

 

 

 

 

233,356,500

 

 

 

233,357

 

 

 

(228,690 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,667

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redwd III (12/314) ($3,287)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $35,286)

 

 

 

 

 

 

 

 

 

 

164,350,200

 

 

 

164,350

 

 

 

(161,063 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,287

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (12/5/14) ($11,400)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $640)

 

 

 

 

 

 

 

 

 

 

228,000,000

 

 

 

228,000

 

 

 

(216,600 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Iconic (12/10/14) ($3,148)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $46,645)

 

 

 

 

 

 

 

 

 

 

128,482,577

 

 

 

128,483

 

 

 

(125,335 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,148

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WHC (12/10/14) ($4,800)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $38,200)

 

 

 

 

 

 

 

 

 

 

200,000,000

 

 

 

200,000

 

 

 

(195,200 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tonaquint (11/10//14) ($3,937)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $44,309)

 

 

 

 

 

 

 

 

 

 

157,500,000

 

 

 

157,500

 

 

 

(153,563 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,937

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JSJ (12/16/14) ($7,698)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal. of loan ($12,130)

 

 

 

 

 

 

 

 

 

 

307,937,698

 

 

 

307,938

 

 

 

(300,240 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,698

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JMJ (12/22/14) ($19,080)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $24,842)

 

 

 

 

 

 

 

 

 

 

318,000,000

 

 

 

318,000

 

 

 

(298,920 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,080

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Thomas Kidd -

 

 

 

 

 

 

 

 

 

 

240,000,000

 

 

 

240,000

 

 

 

(216,000 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adar (12/30/14) ($3,846)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $48,154)

 

 

 

 

 

 

 

 

 

 

153,846,000

 

 

 

153,846

 

 

 

(150,000 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,846

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (12/31/14) ($2,340)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $0)

 

 

 

 

 

 

 

 

 

 

46,800,000

 

 

 

46,800

 

 

 

(44,460 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,340

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (12/31/14) ($9,060)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ($23,440)

 

 

 

 

 

 

 

 

 

 

181,200,000

 

 

 

181,200

 

 

 

(172,140 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,060

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LG (12/31/14) ($5,121)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $4,800)

 

 

 

 

 

 

 

 

 

 

256,044,000

 

 

 

256,044

 

 

 

(250,923 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,121

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tonaquint (1/12/14) ($4k)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $40,559)

 

 

 

 

 

 

 

 

 

 

160,000,000

 

 

 

160,000

 

 

 

(156,000 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,000

 

 

 
Page 25 of 56
 

 

Domark International, Inc

STATEMENT OF STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid in

 

 

Stock

 

 

Accumulated

 

 

Treasury Stock

 

 

 

 

 

Stockholders'

 

 

 

Amt.

 

 

Shares

 

 

Shares

 

 

Amt.

 

 

Capital

 

 

Payable

 

 

Deficit

 

 

Shares

 

 

Amount

 

 

OCI

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock issued for loan conv.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KBM (2/16/15) ($14,030)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bal of loan ( $9,410)

 

 

 

 

 

 

 

 

 

 

280,600,000

 

 

 

280,600

 

 

 

(266,570 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,030

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,902 )

 

 

(37,902 )
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unmortized disc. Accretion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

126,403

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

126,403

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,020,655 )

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,020,655 )
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance May 31,1015

 

 

50,000

 

 

$ 50

 

 

 

8,805,932,169

 

 

$ 8,805,105

 

 

$ 36,219,642

 

 

$ 858,000

 

 

48.962,791

 

 

 

(124,819,802 )

 

 

(124,820 )

 

 

(126,453 )

 

 

3,330,440

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 26 of 56
 

 

DOMARK INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

For the year ended

 

 

 

May 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net Loss

 

$ (3,020,655 )

 

$ (3,726,869 )
 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

217,440

 

 

 

62,685

 

Common stock issued as compensation - consultants

 

 

79,623

 

 

 

-

 

Common stock issued as compensation

 

 

-

 

 

 

823,355

 

Non cash interest expense

 

 

805,370

 

 

 

451,988

 

Loss (gain) on derivative valuation

 

 

815,302

 

 

 

1,213,154

 

Currency loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

-

 

 

 

13,323

 

Accounts payable and accrued expenses

 

 

798,725

 

 

 

(152,062 )

Accounts payable - related party

 

 

956

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(303,239 )

 

 

(1,323,233 )
 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Cash paid for investments

 

 

-

 

 

 

(159,550 )

Cash paid for loan receivable from consultant

 

 

-

 

 

 

(36,203 )
 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

-

 

 

 

(195,753 )
 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from convertible notes payable

 

 

208,863

 

 

 

1,162,500

 

Payments made on amounts due under License Agreement with Wazzamba S. A.

 

 

-

 

 

 

(75,075 )

Proceeds from loans payable to consultants and stockholders

 

 

131,703

 

 

 

262,542

 

Payments made on loans payables to consultants & stockholders

 

 

-

 

 

 

(10,541 )

Proceeds received from notes payable

 

 

-

 

 

 

180,000

 

Net cash provided by financing activities

 

 

340,566

 

 

 

1,519,426

 

 

 

 

 

 

 

 

 

 

Other comprehensive income ( loss ) effect of exchange rate changes on cash

 

 

(37,902 )

 

 

-

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

 

(575 )

 

 

440

 

CASH BALANCE - BEGINNING OF PERIOD

 

 

460

 

 

 

20

 

CASH BALANCE ( BANK OVERDRAFT ) - END OF PERIOD

 

$ (115 )

 

$ 460

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ 20,424

 

 

$ 9,700

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 27 of 56
 

 

DOMARK INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

For the year ended

 

 

 

May 31,

 

 

 

2015

 

 

2014

 

SUPPLEMENT SCHEDULE OF NON-CASH INVESTING

 

 

 

 

 

 

AND FINANCING ACTIVITIES:

 

 

 

 

 

 

Licensing Agreement with Wazzamba SA in exchange for amounts due

 

 

 

 

 

 

under Licensing agreement with Wazzamba SA

 

$ -

 

 

$ 300,000

 

Shares issued for settlement of loans payable to consultants

 

 

 

 

 

 

 

 

and stockholders

 

$ 65,102

 

 

$ 159,991

 

Shares issued for settlement of convertible notes payable

 

$ 487,998

 

 

$ 731,329

 

Shares issued for patent acquisition

 

$ -

 

 

$ 35,500

 

Shares issued for equity interests in Imagic Ltd.

 

$ -

 

 

$ 796,700

 

Shares issued for equity interest in Barefoot Science Products & Services, Inc.

 

 

-

 

 

 

45,000

 

Convertible notes payable issued for equity interests in Imagic Ltd.

 

$ -

 

 

$ 150,000

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 
Page 28 of 56
 

 

DOMARK INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED MAY 31, 2015 AND MAY 31, 2014

 

NOTE 1 – DESCRIPTION OF BUSINESS

 

DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. The Company devotes most of its time developing its products. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.

 

On February 29, 2012, the Company formed a new wholly owned subsidiary, Solawerks, Inc., in the State of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solawerk's current focus is to develop and distribute the IR Charger, which is a combined cover and charging case for Apple's iPad, and Samsung products. Solawerks competes in a market that also includes 3D Systems (DDD), Dell ( DELL ), and Hewlett Packard (HPQ). Currently the charter is in default with the Secretary of State of Nevada.

 

On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.

 

On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company's corporate operations based in Toronto, Ontario, Canada.

 

On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. ("Zaktek"). Zaktek's main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhoneÒ and Samsung Galaxy products to improve functionality including video and gaming abilities.

 

On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.

 

On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

 

NOTE 2 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. For the period March 30, 2006 (inception) to May 31, 2015, the Company incurred net losses of $48,962,791. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders.

 

These factors raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

 

 
Page 29 of 56
 

 

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

RECENT ACCOUNTNG PRONOUNCEMENTS

 

In June 2014, The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-10, "Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation" ("ASU 2014-10"). ASU 2014-10 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 2014-10, the Company has elected early application of this standard for the accompanying consolidated financial statements for the years ended May 31, 2015 and 2014.

 

The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.

 

PRINCIPLES OF CONSOLIDATION

 

The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solarwerks, Inc., and MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 810-10-15-3.

 

FOREIGN CURRENCY TRANSLATION AND TRANSACTION GAINS AND LOSSES

 

We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders' deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of operations related to the recurring measurement and settlement of such transactions. The translation rate for the Canadian dollar as of May 31, 2015 was $0.80.

 

USE OF ESTIMATES

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

 

The primary management estimates included in these consolidated financial statements are the fair value of Company stock tendered in various non-monetary transactions and the fair value of the derivative liability for convertible notes payable.

 

CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At May 31, 2015 and 2014, cash and cash equivalents consisted only of cash in the bank, or amounts due to bank.

 

LOAN RECEIVABLE FROM CONSULTANT

 

The loan receivable from consultant is a short term, less than one year note, due July 15, 2015, and is non-interest bearing.

 

 
Page 30 of 56
 

 

NET LOSS PER COMMON SHARE

 

Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.

 

For the years ended May 31, 2015 and 2014, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:

 

 

 

  Common Shares Equivalent

 

 

 

  Years Ended May 31,

 

 

 

  2015

 

 

2014

 

Convertible notes payable

 

 

23,613,258,824

 

 

 

1,568,946,386

 

Series A convertible preferred stock

 

 

50,000,000

 

 

 

50,000,000

 

Warrants

 

 

850,000

 

 

 

850,000

 

 

 

 

 

 

 

 

 

 

Total common shares equivalent

 

 

23,664,118,824

 

 

 

1,619,796,386

 

 

INTANGIBLE ASSETS

 

Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.

 

RECLASSIFICATION

 

A reclassification has been made to the prior period consolidated balance sheet to conform to the current period presentation. This reclassification had no effect on previous reported results of operations. The Company has shown separately the amount of treasury stock from the Common stock in the consolidated balance sheet and statement of stockholders' deficit.

 

IMPAIRMENT OF LONG-LIVED ASSETS

 

In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

STOCK-BASED COMPENSATION

 

The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.

 

 
Page 31 of 56
 

 

ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.

 

RESEARCH AND DEVELOPMENT

 

All research and development expenditures are expensed as incurred.

 

REVENUE RECOGNITION

 

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

 

NOTE 4 – INVESTMENTS

 

Investments consist of:

 

 

 

May 31,
2015

 

 

May 31,
2014

 

Imagic Ltd. - 40% equity interest

 

$ 1,094,166

 

 

$ 1,094,166

 

Barefoot Science Products & Services Inc. - 15% equity interest

 

 

50,000

 

 

 

50,000

 

Total

 

$ 1,144,166

 

 

$ 1,144,166

 

 

The cost of the 40% equity interest in Imagic Ltd. at May 31, 2015 consists of:

 

July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.

 

$ 697,500

 

December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.

 

 

99,200

 

Cash payments to or for the benefit of Imagic Ltd.

 

 

147,466

 

Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings

 

 

150,000

 

Total

 

$ 1,094,166

 

 

Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the year ended May 31, 2015.

 

 
Page 32 of 56
 

 

The cost of the 15% equity interest in Barefoot Science Products & Services Inc. consists of:

 

January 25, 2013 cancellation of the Marketing and Distribution Agreement dated June 20, 2012

 

$ 5,000

 

May 14, 2014 issuance of 15,000,000 shares of DoMark common stock to Lance Todd pursuant to Agreement of Understanding dated March 27, 2014

 

 

45,000

 

Total

 

$ 50,000

 

 

On January 25, 2013, the Company executed an agreement with Barefoot Science Products & Services Inc. ("Barefoot Science") which cancelled the Marketing and Distribution Agreement dated June 20, 2012 and which provided the Company a 15% equity interest in Barefoot Science. As a result, the Company recognized an impairment charge of $4,605,480 in the year ended May 31, 2013 to write off the remaining unamortized prepaid license fees at February 28, 2013 ($4,605,480) and to record the estimated fair value of the 15% equity interest in Barefoot Science at $5,000. On March 27, 2014, DoMark executed an Agreement of Understanding with Barefoot Science and its other owner Lanee Todd. Among other things, the Agreement of Understanding provides for (1) DoMark's issuance of 15,000,000 shares of DoMark common stock to Lance Todd (which occurred May 14, 2014), (2) future monthly remittances of 15% of Barefoot Science's profit (as defined) to DoMark, and (3) the addition of R. Brentwood Strasler (DoMark's non-executive Chairman) to Barefoot Science's Board of Directors.

 

Barefoot Science has developed a patented foot strengthening system through insertion of an insole system or by incorporation right into the design of shoes. Barefoot Science shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.

 

NOTE 5 – LICENSING AGREEMENT WITH WAZZAMBA SA

 

During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the "Licensor"). The agreement provides the Company an exclusive license to use certain technology (which permits third-party subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor "Flat Fee" compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus "Revenue Share" compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.

 

At February 28, 2014, the Company recorded this Licensing Agreement and the related "Flat Fee" liability as an intangible asset and liability in the amount of $300,000. In the three months ended May 31, 2014, the Company paid $75,075 of the first $100,000 "Flat Fee" installment due the Licensor under the agreement. The other $24,925 due is presently past due. The Company is currently in negotiations with the Licensor to have its rights pursuant to the Licensing Agreement converted into an equity interest in a new entity to be owned by both the Company and the Licensor. The new entity would have worldwide rights to Licensor's technology now entitled "Monetizer 101".

 

Licenses, net of accumulated amortization, consist of:

 

 

 

May 31,

 

 

May 31,

 

 

 

2015

 

 

2014

 

Wazzamba, S.A.

 

$ 300,000

 

 

$ 300,000

 

Bioharmonics

 

 

10,000

 

 

 

10,000

 

Subtotal

 

 

310,000

 

 

 

310,000

 

Accumulated amortization

 

 

(268,338 )

 

 

(60,898 )

Total

 

$ 41,662

 

 

$ 249,102

 

 

 
Page 33 of 56
 

 

NOTE 6 – NOTE PAYABLE TO BANK

 

In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $198,000 bears interest at a rate at 10% payable monthly, is due in full on December 31, 2014, and is secured by a Common Stock Reserve (as defined in the Loan Agreement), a Guaranty of Payment from the Company's chief financial officer and his wife, and certain real property owned by the Company's chief financial officer and his wife. Currently the loan is in default and management is working on a loan modification with the Lender. Past due interest of $18,000 was added to principal loan of $180,000.

 

NOTE 7 – LOANS PAYABLE TO RELATED PARTIES, CONSULTANTS, AND STOCKHOLDERS

 

Loans payable to related parties, consultants, and stockholders consist of:

 

 

 

May 31,

 

 

May 31,

 

 

 

2015

 

 

2014

 

Consultant and stockholder

 

$ 80,796

 

 

$ 90,402

 

Chief executive officer/Pres. of DoMark International, Inc.

 

 

45,850

 

 

 

47,500

 

Non Exec. Chairman of Board of DoMark International, Inc.

 

 

-

 

 

 

11,875

 

Chairman of Barefoot Science and affiliate

 

 

21,500

 

 

 

21,500

 

Consultant

 

 

16,097

 

 

 

16,097

 

Consultant

 

 

17,085

 

 

 

1,598

 

Consultant

 

 

8,600

 

 

 

-

 

Total

 

$ 189,928

 

 

$ 188,972

 

 

The loans payable to related parties, consultants, and stockholders are informal and do not provide for interest or a stated maturity date.

 

 
Page 34 of 56
 

 

NOTE 8 – CONVERTIBLE NOTES PAYABLE

 

At May 31, 2015 the convertible notes payable consisted of ;

 

Date of

 

 

 

Interest

 

 

Maturity

 

Principal

 

 

Unamortized

 

 

Net

 

Note

 

Noteholder

 

Rate

 

 

Date

 

Amount

 

 

Discount

 

 

Note

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12/19/13

 

JMJ Financial Inc

 

 

10 %

 

12/19/14

 

$ 24,842 (i)

 

$ 0

 

 

$ 24,842

 

3/7/14

 

JSJ Investments, Inc.

 

 

12 %

 

10/7/14

 

 

12,130 (g)

 

 

0

 

 

 

12,130

 

3/28/14

 

Redwood Fund III

 

 

10 %

 

9/28/14

 

 

35,122 (f)

 

 

0

 

 

 

35,122

 

3/18/14

 

Redwood Managament, LLC.

 

 

10 %

 

9/28/14

 

 

50,000 (g)

 

 

0

 

 

 

50,000

 

4/14/14

 

WHC Capital, Inc

 

 

12 %

 

10/14/14

 

 

38,200 (i)

 

 

0

 

 

 

38,200

 

4/11/14

 

Tonaquint, Inc

 

 

12 %

 

10/11/14

 

 

40,559 (g)

 

 

0

 

 

 

40,559

 

4/24/14

 

JSJ Investments, Inc.

 

 

12 %

 

10/24/14

 

 

50,000 (g)

 

 

0

 

 

 

50,000

 

5/12/14

 

Iconic Holdings, LLC

 

 

10 %

 

11/12/14

 

 

46,645 (g)

 

 

0

 

 

 

46,645

 

5/16/14

 

KBM Worldwide, Inc

 

 

8 %

 

11/14/14

 

 

9,410 (l)

 

 

0

 

 

 

9,410

 

6/3/14

 

Adar Bays, Inc

 

 

8 %

 

12/12/14

 

 

48,654 (g)

 

 

0

 

 

 

48,654

 

6/23/14

 

JMJ Financial Inc

 

 

10 %

 

12/23/14

 

 

50,000 (i)

 

 

0

 

 

 

50,000

 

7/3/14

 

LG Capital, Inc

 

 

8 %

 

1/3/15

 

 

36,750 (a)

 

 

0

 

 

 

36,750

 

7/22/14

 

Redwood Fund III

 

 

10 %

 

1/22/15

 

 

100,082 (g)

 

 

0

 

 

 

100,082

 

8/14/14

 

KBM Worldwide, Inc

 

 

8 %

 

2/14/15

 

 

27,500 (l)

 

 

0

 

 

 

27,500

 

10/8/14

 

LG Capital, Inc

 

 

8 %

 

4/8/15

 

 

3,000 (a)

 

 

0

 

 

 

3,000

 

12/2/14

 

Tonaquint, Inc

 

 

12 %

 

6/2/15

 

 

10,000 (g)

 

 

6,849

 

 

 

3,151

 

12/5/14

 

LG Capital, Inc.

 

 

8 %

 

6/5/15

 

 

9,500 (a)

 

 

6,462

 

 

 

3038

 

1/7/15

 

LG Capital Inc

 

 

8 %

 

7/7/15

 

 

22,500 (a)

 

 

20,763

 

 

 

1737

 

3/15/15

 

Curran

 

 

10 %

 

3/15/15

 

 

25,000 (l)

 

 

24,864

 

 

 

136

 

 

 

Totals

 

 

 

 

 

 

 

$ 639,894

 

 

$ 58,938

 

 

$ 580,956

 

 

Legend

 

(a)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.

 

(b)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

(c)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.

 

(d)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.

 

(e)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.

 

(f)      At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

 
Page 35 of 56
 

 

(g)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the average of the three lowest bid prices during the 20 trading days prior to the notice of conversion.

 

(h)     At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 20% of the lowest trading price during the 20 trading days prior to the notice of conversion.

 

(i)       At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest trading price during the 20 trading days prior to the notice of conversion.

 

(j)      At noteholder's option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 15 trading days prior to the notice of conversion.

 

NOTE 9 – STOCKHOLDERS' DEFICIT

 

Series A Convertible Preferred Stock

 

Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.

 

Common Stock Issuances

 

On June 17, 2013, the Company issued 2,500,000 shares of common stock in satisfaction of a $50,000 loan payable.

 

On June 29, 2013, the Company issued 2,500,000 shares of common stock (valued at $250,000) to a consultant for services rendered.

 

On July 5, 2013, the Company issued 250,000 shares of common stock (valued at $22,500) to a consultant for website development services.

 

On July 9, 2013, the Company issued 75,000 shares of common stock (valued at $6,675) to a consultant for services rendered.

 

On July 17, 2013, the Company issued 500,000 shares of common stock (valued at $41,650) to a consultant for investor relations services.

 

On July 22, 2013, the Company issued 2,874,550 shares of common stock in satisfaction of a $57,491 loan payable.

 

On July 22, 2013, the Company issued 7,500,000 shares of common stock (valued at $697,500) in connection with the acquisition of a 19% equity interest in Imagic Ltd. See Note 4.

 

On August 15, 2013, the Company issued 500,000 shares of common stock (valued at $35,500) to Bioharmonics Technologies Corp. in connection with the acquisition of certain inventions and related patents and patent applications.

 

On August 26, 2013, the Company issued 2,000,000 shares of common stock (valued at $133,000) to a consultant for services rendered.

 

On August 28, 2013, the Company issued 1,114,206 shares of common stock to Asher Enterprises, inc. in satisfaction of $14,000 principal amount of convertible notes payable and $26,000 of fees.

 

On September 18, 2013, the Company issued 856,164 shares of common stock to Asher Enterprises, Inc. in satisfaction of $25,000 principal amount of convertible notes payable.

 

On October 9, 2013, the Company issued 1,000,000 shares of common stock (valued at $45,600) to a consultant for services rendered.

 

On October 10, 2013, the Company issued 250,000 shares of common stock (valued at $12,500) to a consultant for services rendered.

 

 
Page 36 of 56
 

 

On November 4, 2013, the Company issued 903,261 shares of common stock to Asher Enterprises, Inc. in satisfaction of $14,000 principal amount of convertible notes payable and $500 of costs.

 

On November 4, 2013, the Company issued 1,153,846 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of principal amount of convertible notes payable.

 

On November 4, 2013, the Company issued 3,500,000 shares of common stock in satisfaction of a $52,500 loan payable.

 

On November 12, 2013, the Company issued 1,630,435 shares of common stock to Asher Enterprises, Inc. in satisfaction of $15,000 principal amount of convertible notes payable.

 

On November 14, 2013, the Company issued 3,999,200 shares of common stock to Iconic Holdings, LLC in satisfaction of $13,197 principal amount of convertible notes payable.

 

On November 15, 2013 the Company issued 175,000 shares of common stock (valued at $1,750) to a consultant for services rendered.

 

On November 19, 2013, the Company issued 3,456,597 shares of common stock to Asher Enterprises, Inc. in satisfaction of $2,500 principal amount of convertible notes payable and $17,548 of costs.

 

On November 19, 2013, the Company issued 8,850,572 shares of common stock to Iconic Holdings, LLC in satisfaction of $22,126 principal amount of convertible notes payable.

 

Effective December 3, 2013, the Company issued 8,000,000 shares of common stock (valued at $99,200) to Meadow Grove Ltd. in connection with the acquisition of a 9% equity interest in Imagic Ltd. See Note 4.

 

On December 4, 2013, the Company issued 7,072,457 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,852 principal amount of convertible notes payable.

 

On December 18, 2013, the Company issued 5,445,005 shares of common stock to Iconic Holdings, LLC in satisfaction of $11,435 principal amount of convertible notes payable.

 

On December 26, 2013 the Company issued 4,166,667 shares of common stock to Asher Enterprises, Inc. in satisfaction of $20,000 principal amount of convertible notes payable.

 

On December 30, 2013, the Company issued 4,791,667 shares of common stock to Asher Enterprises, Inc. in satisfaction of $23,000 principal amount of convertible notes payable.

 

On January 6, 2014, the Company issued 1,305,556 shares of common stock to Asher Enterprises, Inc. in satisfaction of $7,050 principal amount of convertible notes payable.

 

On January 13, 2014, the Company issued 6,198,762 shares of common stock to Iconic Holdings, LLC in satisfaction of $13,017 principal amount of convertible notes payable.

 

On January 23, 2014, the Company issued 6,436,781 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,000 principal amount of convertible notes payable.

 

On February 3, 2014, the Company issued 7,498,890 shares of common stock to Iconic Holdings, LLC in satisfaction of $14,998 principal amount of convertible notes payable.

 

On February 6, 2014, the Company issued 4,900,000 shares of common stock to JSJ Investments, Inc. in satisfaction of $17,150 principal amount of convertible notes payable.

 

On February 11, 2014, the Company issued 3,000,000 shares of common stock to JMJ Financial Inc. in satisfaction of $10,800 principal amount of convertible notes payable.

 

On February 11, 2014, the Company issued 4,901,960 shares of common stock to Continental Equities, LLC in satisfaction of $20,000 principal amount of convertible notes payable.

 

 
Page 37 of 56
 

 

On February 13, 2014, the Company issued 5,000,000 shares of common stock to Black Mountain Equities, Inc. in satisfaction of $15,000 principal amount of convertible notes payable.

 

On February 25, 2014, the Company issued 4,000,000 shares of common stock to JMJ Financial Inc. in satisfaction of $12,000 principal amount of convertible notes payable.

 

On February 26, 2014, the Company issued 3,278,688 shares of common stock to Continental Equities, LLC in satisfaction of $10,000 principal amount of convertible notes payable.

 

On March 3, 2014, the Company issued 12,000,000 shares of common stock (valued at $80,400) to a consultant for services.

 

On March 3, 2014, the Company issued 6,419,120 shares of common stock to Redwood Fund III in satisfaction of $10,913 principal amount of convertible payable.

 

On March 6, 2014, the Company issued 6,755,135 shares of common stock to Redwood Fund III in satisfaction of $10,133 principal amount of convertible payable.

 

On March 6, 2014, the Company issued 3,990,435 shares of common stock to JSJ Investments in satisfaction of $9,178 principal amount of convertible payable.

 

On March 6, 2014, the Company issued 7,108,733 shares of common stock to Redwood Fund III in satisfaction of $10,663 principal amount of convertible payable.

 

On March 17, 2014, the Company issued 5,668,934 shares of common stock (valued at $32,880) to a consultant for services.

 

On March 17, 2014, the Company issued a total of 27,000,000 shares of common stock (valued at $156,600) to officers for services.

 

On March 18, 2014, the Company issued 6,818,182 shares of common stock to Asher Enterprises in satisfaction of $15,000 principal amount of convertible notes payable.

 

On March 18, 2014, the Company issued 10,053,100 shares of common stock to Redwood Fund III in satisfaction of $12,968 principal amount of convertible notes payable.

 

On March 19, 2014, the Company issued 2,000,000 shares of common stock (valued at $9,800) to a consultant for services.

 

On March 20, 2014, the Company issued 8,863,636 shares of common stock to Asher Enterprises in satisfaction of $19,500 principal amount of convertible notes payable.

 

On March 24, 2014, the Company issued 11,081,400 shares of common stock to Redwood Fund III in satisfaction of $13,187 principal amount of convertible notes payable.

 

On March 25, 2014, the Company issued 6,000,000 shares of common stock to Asher Enterprises in satisfaction of $11,400 principal amount of convertible notes payable.

 

On March 28, 2014, the Company issued 2.766.667 shares of common stock to Asher Enterprises in satisfaction of $4,150 principal amount of convertible notes payable.

 

On March 28, 2014, the Company issued 11,652,000 shares of common stock to Redwood Fund III in satisfaction of $6,642 principal amount of convertible notes payable.

 

 
Page 38 of 56
 

 

On April 1, 2014, the Company issued 17,647,059 shares of common stock to Black Mountain Equities in satisfaction of $15,000 principal amount of convertible notes payable.

 

On April 2, 2014, the Company issued 6,900,000 shares of common stock to JMJ Financial in satisfaction of $7,038 principal amount of convertible notes payable.

 

On April 2, 2014, the Company issued 12,273,600 shares of common stock to Redwood Fund III in satisfaction of $6,996 principal amount of convertible notes payable.

 

On April 8, 2014, the Company issued 12,916,695 shares of common stock to Redwood Fund III in satisfaction of $7,363 principal amount of convertible notes payable.

 

On April 10, 2014, the Company issued 17,647,059 shares of common stock to Black Mountain Equities in satisfaction of $15,000 principal amount of convertible notes payable.

 

On April 10, 2014, the Company issued 31,749,235 shares of common stock to JMJ Financial in satisfaction of $32,384 principal amount of convertible notes payable.

 

On April 10, 2014, the Company issued 13,593,400 shares of common stock to Redwood Fund III in satisfaction of $7,748 principal amount of convertible notes payable.

 

On April 10, 2014, the Company issued 10,220,000 shares of common stock to JSJ Investments in satisfaction of $4,088 principal amount of convertible notes payable.

 

On April 16, 2014, the Company issued 14,678,154 shares of common stock to Redwood Fund III in satisfaction of $8,367 principal amount of convertible notes payable.

 

On April 16, 2014, the Company issued 15,500,000 shares of common stock to Black Mountain Equities in satisfaction of $15,500 principal amount of convertible notes payable.

 

On April 23, 2014, the Company issued 10,900,000 shares of common stock to JMJ Financial in satisfaction of $10,900 principal amount of convertible notes payable.

 

On April 29, 2014, the Company issued 22,716,552 shares of common stock to JSJ Investments in satisfaction of $14,009 principal amount of convertible notes payable.

 

On May 5, 2014, the Company issued 15,000,000 shares of common stock to Barefoot Science Products & Services Inc.

 

On May 6, 2014, the Company issued 30,000,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $15,000 principal amount of convertible payable.

 

On May 6, 2014, the Company issued 4,492,470 shares of common stock to Redwood Fund III in satisfaction of $3,074 principal amount of convertible payable.

 

On May 14, 2014, the Company issued 33,065,760 shares of common stock to Iconic Holdings, LLC in satisfaction of $16,533 principal amount of convertible payable.

 

On May 14, 2014, the Company issued 15,483,636 shares of common stock to JSJ Investments in satisfaction of $8,516 principal amount of convertible notes payable.

 

On May 27, 2014, the Company issued 15,000,000 shares of common stock (valued at $30,000) to a consultant for services.

 

On May 28, 2014, the Company issued 17,545,455 shares of common stock to Asher Enterprises, Inc. in satisfaction of $19,300 principal amount of convertible notes payable.

 

 
Page 39 of 56
 

 

On May 29, 2014, the Company issued 37,500,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $15,000 principal amount of convertible notes payable.

 

On May 29, 2014, the Company issued 17,600,000 shares of common stock to Iconic Holdings, LLC in satisfaction of $17,600 principal amount of convertible notes payable.

 

On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable.

 

On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable.

 

On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable.

 

On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable

 

On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable.

 

On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable.

 

On December 16,, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable.

 

On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable.

 

On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable.

 

On October 1, 2014, the Company issued 141,004,800 shares of common stock to Redwood Fund III, Inc. in satisfaction of $2,680 of principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 64,500,000 shares of common stock to KBM Worldwide, Inc., Inc. in satisfaction of $3,225 principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 87,800,000 shares of common stock to KBM Worldwide, Inc.in satisfaction of $4,390 principal amount of convertible notes payable..

 

On October 16, 2014, the Company issued 92,480,000 shares of common stock to WHC Captial, Inc. in satisfaction of $ 4,624 principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 175,750,000 shares of common stock to Tonaquint, Inc. in satisfaction of $4,393 principal amount of convertible notes payable.

 

 
Page 40 of 56
 

 

On October 20, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.

 

On October 20, 2014, the Company issued 148,392,800 shares of common stock to Redwood Fund, III, Inc. in satisfaction of $2,968 principal amount of convertible notes payable.

 

On October 30,, 2014, the Company issued 184,359,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $3,687 principal amount of convertible notes payable.

 

On November 10, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.

 

On November 10, 2014 the Company issued 157,500,000 shares of common stock Tonaquint, Inc in satisfaction of $3,937 principal amount of convertible notes payable..

 

On November 11, 2014, the Company issued 324,186,800 shares of common stock to Iconic Holdings, LLC. in satisfaction of $8,105 principal amount of convertible notes payable.

 

On November 19, 2014, the Company issued 107,520,000 shares of common stock to WHC Capital Inc. in satisfaction of $5,376 principal amount of convertible notes payable.

 

On November 19, 2014, the Company issued 156,167,800 shares of common stock to KBM Worldwide, Inc in satisfaction of $7,615 principal amount of convertible noted payable.

 

On November 19, 2014,, the Company issued 222,151,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $4,443 principal amount of convertible notes payable.

 

On November 20, 2014, the Company issued 212,530,662 shares of common stock to Iconic Holdings, LLC in satisfaction of $5,207 principal amount of loan payable.

 

On December 1, 2014, the Company issued 233,356,500 shares of common stock for LG Capital, Inc. in satisfaction of $4,667 of principal amount of convertible notes payable.

 

On December 3, 2014, the Company issued 164,350,200 shares of common stock for Redwood Fund III, Inc.in satisfaction of $ 3,287 of principal amount of convertible notes payable.

 

On December 5, 2014, the Company issued 228,000,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $11,400 of principal amount of convertible notes payable.

 

On December 10, 2014, the Company issued 128,428,577 shares of common stock for Iconic Holdings, LLC in satisfaction of $ 3,148 of principal amount of convertible notes payable.

 

 
Page 41 of 56
 

 

On December 10, 2014, the Company issued 200,000,000 shares of common stock for WHC Capital, Inc. in satisfaction of $4,800 of principal amount of convertible notes payable.

 

On December 10, 2014, the Company issued 157,500,000 shares of common stock for Tonaquint, Inc. in satisfaction of $3,937 of principal amount of convertible notes payable.

 

On December 16, 2014, the Company issued 307,937,698 shares of common stock for JSJ Investments, Inc. in satisfaction of $7,698 of principal amount of convertible notes payable.

 

On December 22, 2014, the Company issued 318,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $19,080 of principal amount of convertible notes payable.

 

On December 30, 2014, the Company issued 153,846,000 shares of common stock for Adars Bay, Inc. in satisfaction of $3,846 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 181,200,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 256,044,000 shares of common stock for LG Capital, Inc.in satisfaction of $5,121 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 46,800,000 shares of common stock for KBM Worldwide, Inc. in satisfaction of $2,340 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 181,200,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $9,060 of principal amount of convertible notes payable.

 

On December 31, 2014, the Company issued 256,044,000 shares of common stock to LG Capital, Inc., Inc. in satisfaction of $5,121 principal amount of convertible notes payable.

 

On January 12, 2015, 2014, the Company issued 160,000,000 shares of common stock to Tonaquint, Inc.in satisfaction of $4,000 principal amount of convertible notes payable..

 

On February 17, 2015, the Company issued 280,600,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $ 14,030 principal amount of convertible notes payable.

 

Warrants to Purchase Common Stock

 

A summary of warrant activity for the years ended May 31, 2015 and 2014 follows:

 

 

 

Number of Warrants

 

 

Weighted Average Exercise Price

 

Outstanding May 31, 2012

 

 

-

 

 

$ -

 

Granted

 

 

850,000

 

 

 

0.42

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Outstanding at May 31, 2015

 

 

850,000

 

 

 

0.42

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

Outstanding at May 31, 2015

 

 

850,000

 

 

$ 0.42

 

 

 
Page 42 of 56
 

 

Warrants outstanding at May 31, 2015 consist of:

 

Date Granted

 

Number Outstanding

 

 

Exercise
price

 

 

Expiration
Date

 

June 1, 2012

 

 

100,000

 

 

$ 1.00

 

 

June 1, 2015

 

June 12, 2012

 

 

150,000

 

 

$ 1.00

 

 

June 12, 2015

 

June 26, 2012

 

 

100,000

 

 

$ 1.00

 

 

June 26, 2015

 

January 1, 2013

 

 

500,000

 

 

$ 0.01

 

 

January 1, 2016

 

Totals

 

 

850,000

 

 

 

 

 

 

 

 

 

NOTE 10 – FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILIITY

 

The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based derivative financial instruments, the Companyuses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

During the year ended May 31, 2014, the Company entered into numerous convertible note agreements.Under ASC-815, the conversion options embedded in the notes payable described in Note 8 require derivate liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.

 

As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

 

The three levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management's best estimate of fair value.

 

 
Page 43 of 56
 

 

Derivative liability — the Company's derivative liability is classified within Level 3 of the fair value hierarchy.

 

The Company uses the Black Scholes Option Pricing Model to value its option based derivatives based upon the following assumptions: dividend yield of -0-%, volatility of 100%, risk free interest rate ranging from 0.04% to 0.13 % and an expected term equal to the remaining term of the note.

 

The following table sets forth, by level, the fair value hierarchy the Company's derivative liabilities, from their convertible promissory notes payable, that were accounted for at fair value as of May 31, 2015 and May 31, 2014.

 

Recurring Fair Value Measurements

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liability – May 31, 2015

 

$ -

 

 

$ -

 

 

$ 2,564,280

 

 

$ 2,564,280

 

Derivative liability – May 31, 2014

 

$ -

 

 

$ -

 

 

$ 1,748,982

 

 

$ 1,748,982

 

 

NOTE 11 – INCOME TAXES

 

The Company has available net operating loss carry-forwards for financial statement and federal income tax purposes. These loss carry-forwards expire if not used within 20 years from the year generated. The Company's management has decided a valuation allowance is necessary to reduce any tax benefits because the available benefits are more likely than not to expire before they can be used. The tax based accumulated deficit creates tax benefits in the amount of $5,068,598 from inception through May 31, 2015.

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax liabilities and assets as of May 31, 2015 and 2014 are as follows:

 

 

 

May 31,

 

 

2015

 

 

2014

 

Deferred tax assets

 

 

5,668,598

 

 

 

5,068,598

 

Valuation allowance

 

 

(5,668,598 )

 

 

(5,068,598 )

Total deferred tax assets

 

$ -

 

 

$ -

 

 

The valuation allowance for deferred tax assets as of May 31, 2015 and 2014 was $5,668,598 and $5,068,598, respectively. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not the deferred tax assets would not be realized as of May 31, 2015 and 2014, and maintained a full valuation allowance.

 

 
Page 44 of 56
 

 

Reconciliation between the statutory rate and the effective tax rate is as follows for the years ended May 31, 2015 and 2014:

 

Federal statutory tax rate

 

 

(20.0 )%

Permanent differences and valuation allowance

 

 

(20.0 )%

Effective tax rate

 

 

0.0 %

 

NOTE 12 – COMMITMENTS AND CONTINGENCIES

 

License Agreements

 

On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. ("Bioharmoniecs"). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.

 

In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 5.

 

Employment Agreements

 

On May 25, 2012, the Company entered into an employment agreement with its Non-Exec Chaiman of the Board, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler. The policy has not been implanted as of May 31, 2014. Mr. Strasler resigned on December 1, 2014 and was relieved of all duties and responsibilities of the Company, including but not limited to, Non-Exec Chairman and Secretary.

 

On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Ritchie.

 

Related Party Transactions

 

During the current fiscal years ending May 31, 2015, and May 31, 2014 Mr. Andrew Ritchie was compensated $116,512 and $165,209. Mr. R. Brent Strasler was compensated $26,500 and $115,850 for the same period. For fiscal years ending May 31, 2015 and May 31, 2014 Mr. Andrew Ritchie was owed $47,500 for both years, and Mr. Brent Strasler was owed $0 in May 31, 2015 and $11,85 in May 31, 2014.

 

 
Page 45 of 56
 

 

Lease Agreement

 

On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At May 31, 2015, the future lease commitments on this lease for the years ended May 31, are as follows:

 

2016

 

$ 58,880

 

2017

 

 

59,520

 

2018

 

 

7,936

 

 

 

 

 

 

Total

 

$ 126,336

 

 

NOTE 13 – SUBSQUENT EVENTS

 

On August 12, 2015, the Company issued 1,170,000 shares of our Series B Convertible Preferred Stock to our Chief Executive Officer, Andrew Ritchie, in full payment of $365,708 in accrued compensation owed to him and $45,850 in advances that Mr. Ritchie had made to the Company. These shares are convertible into 9,360,000,000 shares of the Company's common stock at the election of the holder. Also on August 12, 2015, the Company issued Thomas Crompton, our Chief Financial Officer, 780,000 shares of Series B Convertible Preferred Stock in full payment of $203,121 in accrued compensation and $17,085 in advances to the Company. These shares are convertible into 6,240,000,000 shares of the Company's common stock at the election of the holder. The above issuances became effective August 13, 2015, the date of recordation of the certificate of designation of the Company's Series B Convertible Preferred Stock with the Secretary of State of Nevada. Class B Convertible Preferred Stock has voting rights equal to 51% of the voting power of the Company. Each share of Class B Convertible Preferred Stock is convertible into 8,000 shares of common stock at the election of the holder.

 

 
Page 46 of 56
 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Our management team, under the supervision and with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended ("Exchange Act"), as of the last day of the fiscal period covered by this report, May 31, 2013. The term disclosure controls and procedures means our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were not effective as of May 31, 2015.

 

Our principal executive officer and our principal financial officer, are responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Management is required to base its assessment of the effectiveness of our internal control over financial reporting on a suitable, recognized control framework, such as the framework developed by the Committee of Sponsoring Organizations ("COSO"). The COSO framework, published in INTERNAL CONTROL-INTEGRATED FRAMEWORK, is known as the COSO Report. Our principal executive officer and our principal financial officer have chosen the COSO framework on which to base its assessment. Based on this evaluation, our management concluded that our internal control over financial reporting was not effective as of May 31, 2015.

 

There were no changes in our internal control over financial reporting that occurred during the fiscal year ended May 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

 

ITEM 9B. OTHER INFORMATION

 

None. 

 

 
Page 47 of 56
 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

DIRECTORS AND EXECUTIVE OFFICERS

 

Andrew Ritchie is the Company's CEO, President and a director. Mr. Ritchie has over ten years of experience leading and directing companies. His experience includes working for three as the CEO of Easymed Services Inc. where he led the restructuring of the global medical information Technology Company and positioned the company as a global leader in the TeleMedicine sector, Working for two years as the Operations Director at Evening Standard Ltd. (UK), Working for two years as the publisher of The Winnipeg Free Press, at which he reported to the Chairman of the Board and was responsible for 1000 staff, revenue of $120 million, and the leadership of all aspects of the Winnipeg Free Press operations. Working for three years as Vice President of Operations at The Globe and Mail (Canada), Canada's largest selling national newspaper with revenues of approximately $300 million. Mr. Ritchie reported directly to the Publisher/CEO and was responsible for the daily operation of all aspects of the newspaper. Mr. Ritchie is 45 years old.

 

R. Brentwood Strasler was the Company's non-exec chairman & director. Mr. Strasler has more than twenty years of experience in both private industry and the public capital markets and has a broad range of skills and expertise in corporate governance, corporate

 

finance, and other matters faced by emerging companies. Mr. Strasler holds an Economics Degree from the University of Western Ontario and an MBA in International Finance from the University of Notre Dame. Mr. Strasler has been with Domark since May 25, 2012. Mr. Strasler resigned on December 1, 2014 from all responsibilities, duties, and as Non-Exec chairman of the Company. Mr. Strasler is 46 years old.

 

None of our officers or directors have filed any bankruptcy petition, been convicted of or been the subject of any criminal proceedings or the subject of any order, judgment or decree involving the violation of any state or federal securities law within the past ten (10) years.

 

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

 

Section 16(a) of the Exchange Act and rules and regulations of the SEC thereunder require our directors, officers and persons who beneficially own more than 10% of our common stock, as well as certain affiliates of such persons, to file initial reports of their ownership of our common stock and subsequent reports of changes in such ownership with the SEC. Our directors and officers and persons owning more than 10% of our common stock are required by SEC rules and regulations to furnish us with copies of all

 

Section 16(a) reports they file. The Company has determined that the following Section 16(a) filings were not made with the SEC:

 

* R. Brentwood Strasler, our President, did not file a Form 3 within the prescribed time period after his appointment as President. Mr. Strasler was unaware of this requirement. Mr. Strasler has subsequently filed a Form 3 to comply with the SEC.

 

* Andrew Ritchie, our CEO, did not file a Form 3 within the prescribed time period after his appointment as CEO.

 

 
Page 48 of 56
 

  

CORPORATE GOVERNANCE

 

The Company has adopted a code of ethics.The directors of the Company are not independent from the Company. Further, an audit committee composed of the requisite number of independent directors along with a qualified financial expert has not yet been established. Considering the costs associated with procuring and providing the infrastructure to support an independent audit committee and the limited number of transactions considered or consummated by the Company, management has concluded that the risks associated with the lack of an independent audit committee are not justified. Management will periodically re-evaluate this situation.

 

LACK OF SEGREGATION OF DUTIES

 

Management is aware that there is a lack of segregation of duties at the Company due to the small number of employees dealing with general administrative and financial matters. However, at this time management has decided that considering the abilities of the employees now involved and the control procedures in place, the risks associated with such lack of segregation are low and the potential benefits of adding employees to clearly segregate duties do not justify the substantial expenses associated with such increases. Management will periodically re-evaluate this situation.

 

COMMITTEES

 

The Company does not have an audit committee or any standing committees due to the Company's small size.

 

The Company's audit committee has determined that its members are not "audit committee financial experts" within the meaning of federal securities regulations.

 

ITEM 11. EXECUTIVE COMPENSATION

 

SUMMARY COMPENSATION TABLE

 

Name and Principal Position

 

Year

 

Salary
($)

 

 

Bonus

 

 

Stock

Awards
($)

 

 

Warrant

Awards

 

 

All Other Compensation
($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Andrew Ritchie (2)

 

2015

 

 

116,512

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R. Brentwood Strasler (1)

 

2015

 

 

26,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Andrew Ritchie

 

2014

 

 

165,209

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R. Brentwood Strasler (1)

 

2014

 

 

115,850

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

(1)

Mr. Strasler was appointed President, Non Exec. Director, and Corporate Secretary of the Company on May 25, 2012.

 

Mr. Strasler resigned as President, Non-Exec Director, and Corporate Secretary of the Company on December 1, 2014.

 

(2)

Mr. Ritchie was appointed Chief Executive Officer and Director of the Company on June 15, 2012.

 

 
Page 49 of 56
 

 

On May 25, 2012, the Company entered into an employment agreement with its newly appointed President, R. Brentwood Strasler, for a period of three years. Mr. Strasler is entitled to an annual salary of $150,000 and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler will be enrolled in a long term executive option plan no later than three months after the effective date of the employment agreement and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler. As of May 31, 2012, the Company did not accrue any salaries under the employment agreement. In December 2014, Mr. Strasler tendered his resignation as Non exec Chairman and this was accepted by the Board of Directors and Mr. Ritchie, President/CEO.

 

During 2013, the Company did not pay our officers their full salaries due to the Company's financial situation. As a result, Mr. Ritchie and Mr. Strasler converted part of the accrued salaries into common stock pursuant to the Company's 2012 Stock Plan for Directors, Officers, and Consultants.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

EQUITY COMPENSATION PLAN INFORMATION

 

 

 

Number of securities to be issued upon exercise of outstanding options, warrants and rights

 

 

Weighted-average exercise price of outstanding options, warrants and rights

 

 

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

 

 

 

 

 

 

 

 

 

 

 

Plan category

 

 

0

 

 

 

0

 

 

 

0

 

Equity compensation plans approved by security holders

 

 

 

 

 

 

 

 

 

 

 

 

Equity compensation plans not approved by security holders

 

 

100,000

 

 

$ 1

 

 

 

0

 

Total

 

 

100,000

 

 

$ 1

 

 

 

0

 

 

(1)

On January 25, 2013, the Company approved registering an additional 9,900,000 shares of the Company's common stock to its 2012 Stock Plan for Directors, Officers and Consultants ("2012 Stock Plan"). The 2012 Stock Plan originally authorized the issuance of 500,000 shares of the Company's common stock for directors, officers, and employees (including consultants meeting the definition of "employee" under Rule 405 promulgated under the Securities Act). Pursuant to the 2012 Stock Plan, the Company registered 9,900,000 shares of its stock with the SEC on Form S-8 on May 13, 2013.

 

The following table sets forth certain information regarding beneficial ownership of the Company's common stock as of May 31, 2015 by (i) each person who is known by the Company to own beneficially more than 5% of the any class of the Company's voting securities, (ii) each director of the Company, (iii) each of the Chief Executive Officers and the two (2) most highly compensated executive officers who earned in excess of $100,000 for all services in all capacities (collectively, the "Named Executive Officers") and (iv) all directors and executive officers of the Company as a group.

 

The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 and 13d-5 of the Exchange Act, and the information is not necessarily indicative of beneficial ownership for any other purpose and is based on 8,805,932,169 shares outstanding as of May 31, 2015. We believe that each individual or entity named has sole investment and voting power with respect to the securities indicated as beneficially owned by them, subject to community property laws, where applicable, except where otherwise noted.

 

 
Page 50 of 56
 

 

AMOUNT AND NATURE OF BENEFICIAL OWNERSHIP

 

Name and Address

Common Stock

Series A Preferred

Ownership Percentage

Christy Management Limited (1)

-

50,000

47.79% (2)

 

(1) The address for Christy Management Limited is Akara Bldg, 24 De Castro Street, Wickhams Cay 1, Tortola, British Virgin Islands.

 

(2) Percentage beneficial ownership as if preferred stock has been converted into shares of common stock at a ratio of 1,000 shares of common stock for every 1 share of preferred stock.

 

CHANGES IN CONTROL

 

On March 5, 2012, Michael Franklin purchased 50,000 shares of the Company's Series A Preferred Stock from R Thomas Kidd. Our Series A Preferred Stock is convertible into Common Stock at the rate of 1,000 shares of Common for each share of Preferred. In addition, our Preferred stock has voting rights equivalent to 1,000 votes per share. As a result, Mr. Franklin became the controlling shareholder of Domark by virtue of his ownership of 50,000 shares of Preferred Stock with voting rights equivalent to 50,000,000 shares of our Common Stock.

 

On May 25, 2012, Michael Franklin sold 50,000 preferred shares of the Company's Series A Preferred Stock, in a private transaction, to Cristy Management Limited. As a result, Cristy Management Limited has become the controlling shareholder of Domark by virtue of his ownership of 50,000 shares of Series A Preferred Stock with voting rights equivalent to 50,000,000 shares of our Common Stock.

 

Currently a change of control has occurred on August 13, 2014 with Mr. Andrew Ritchie, CEO, and Mr. Thomas Crompton CFO., taking 50.1 % control through the issuance of Preferred Series B convertible shares that convert at 8,000 preferred to 1 common share.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin.

 

On March 5, 2012, the Company's prior Chief Executive Officer returned to treasury 9,771,500 shares of common stock and 50,000 shares of Series A Preferred Stock in connection with an Asset Purchase Agreement dated March 5, 2012.

 

On March 5, 2012, Michael Franklin purchased 50,000 shares of the Company's Series A Preferred Stock from R Thomas Kidd. Our Series A Preferred Stock is convertible into Common Stock at the rate of 1,000 shares of Common for each share of Preferred. In addition, our Series A Preferred Stock has voting rights equivalent to 1,000 votes per share. Upon the conclusion of the Armada transaction, Franklin became the controlling shareholder of Domark by virtue of his ownership of 50,000 shares of Preferred Stock with voting rights equivalent to 50,000,000 shares of our Common Stock.

 

From time to time, the Company's officers have provided loans to the Company. At May 31, 2012, the Company is indebted to Michael Franklin, President of the Company's wholly owned subsidiary Solawerks, Inc., in the amount of $1,000, which amount does not bear interest but is due on demand. This amount reflects advances made to the Company by Mr. Franklin.

 

Neither of the Company's directors are considered independent. For purposes of determining independence, we used the standards set forth by the NASDAQ Stock Exchange, which are not applicable to us.

 

 
Page 51 of 56
 

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

AUDIT FEES

 

The aggregate fees billed by ZBS Group, LLP, for professional services rendered for the audit of the Company's annual financial statements for fiscal year ending May 31, 2015 and May 31, 2014 was $15,000.

 

AUDIT-RELATED FEES

 

The aggregate fees billed by ZBS Group, LLP, for assurance and related services that are reasonably related to the performance of the audit or review of the Company's financial statements for the fiscal years ended May 31, 2015 and 2014, and that are not disclosed in the paragraph captioned "Audit Fees" above, were $33,000 and $33,000, respectively.

 

TAX FEES

 

None.

 

ALL OTHER FEES

 

The Company has not paid its auditors any other fees for audit, audit-related, or tax services.

 

 
Page 52 of 56
 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

FINANCIAL STATEMENTS

 

The information required in Item 15 relating to the Company's financial statements are contained in Item 8 of this Annual Report and incorporated herein by reference.

 

EXHIBITS

 

Exhibit No.

Description of Exhibit

Footnote

 

3.1 (a)

Articles of Incorporation.

1

 

 

 

 

 

(b)

Amendment to Articles of Incorporation.

2

 

 

 

 

 

(c)

Amendment to Articles of Incorporation.

3

 

3.2

Bylaws.

4

 

10.1

Agreement for the Exchange of Common Stock between the Company and Silk for Less, Inc., dated as of June 3, 2011.

5

 

10.2

Media Campaign Agreement between the Company and TVA Media Group, Inc., dated as of June 20, 2011.

6

 

10.3

Escrow Agreement between the Company and Armada Sports & Entertainment, Inc., dated as of June 30, 2011.

7

 

10.4

Asset Purchase Agreement between the Company and USPT, LLC, dated as of August 21, 2011.

8

 

10.6

Memorandum of Agreement between Domark International, Inc. and Xiamen Taiyang Neng Gongsi dated February 29, 2012.

9

 

10.7

Master Credit Agreement between Domark International, Inc. and Infinite Funding, Inc. dated March 2, 2012.

17

 

10.8

Asset Purchase Agreement between Domark International Inc. and R. Thomas Kidd dated March 5, 2012

18

 

10.9

Employment Agreement between Domark International Inc. and R. Brentwood Strasler dated May 25, 2012.

19

 

10.10

Employment Agreement between Domark International Inc. and Andrew Ritchie dated June 15, 2012.

20

 

14

Financial Code of Ethics

21

 

21

Subsidiaries

22

 

23.1

Consent of ZBS Group, LLC

23

 

 
Page 53 of 56
 

 

31.1

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act.*

23

 

31.2

Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes Oxley Act.*

24

 

32.1

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes Oxley Act.*

25

 

32.2

Certification of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes Oxley Act.*

26

 

99.1

Audit Committee Charter

27

 

99.2

Compensation Committee Charter

28

 

101

Interactive data files pursuant to Rule 405 of Regulation S-T.

29

 

Footnotes

 

1. Filed as Exhibit 3.1 to the Company's Form SB-2 filed on August 6, 2006 and incorporated herein by reference.

 

2. Set out in the Company's Form 8-K filed on June 30, 2008 and incorporated herein by reference.

 

3. Filed as Exhibit 3.1 in the Company's Form 8-K filed on January 8, 2009 and incorporated herein by reference.

 

4. Filed as Exhibit 3.2 to the Company's Form SB-2 filed on August 6, 2006 and incorporated herein by reference.

 

5. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 6, 2011 and incorporated herein by reference.

 

6. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 13, 2011 and incorporated herein by reference.

 

7. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 1, 2011 and incorporated herein by reference.

 

8. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on August 22, 2011 and incorporated herein by reference.

 

15. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 29, 2012.

 

17. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 5, 2012.

 

18. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 9, 2012.

 

19. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 25, 2012.

 

 
Page 54 of 56
 

 

20. Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 26, 2012.

 

21. Filed as Exhibit 14.1 to the Company's Annual Report on Form 10-K for the year ending May 31, 2009 and incorporated herein by reference.

 

22. Filed herewith

 

23. Filed herewith

 

24. Filed herewith

 

25. Filed herewith

 

26. Filed herewith

 

27. Filed as Exhibit 99.1 to the Company's Annual Report on Form 10-K for the year ending May 31, 2009 and incorporated herein by reference.

 

28. Filed as Exhibit 99.2. to the Company's Annual Report on Form 10-K for the year ending May 31, 2009 and incorporated herein by reference.

 

29. To be filed by Amendment.

 

 
Page 55 of 56
 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

 

DoMark International, Inc.

 

Date: September 14, 2015

By:

/s/ Andrew Ritchie

Andrew Ritchie

Chief Executive Officer and Principal

Financial Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 14th day of September 2015.

 

By:

/s/ Andrew Ritchie

Andrew Ritchie

Chief Executive Officer and Director

 

By:

/s/ Thomas Crompton

Thomas Crompton

Chief Financial Officer

 

 

 Page 56 of 56